Methods and intermediates for the preparation of optionally radio-labeled imatinib

Details for Australian Patent Application No. 2006257316 (hide)

Owner Novartis AG

Inventors Andres, Hendrik; Bordeaux, Kirk; Voges, Rolf; Salter, Rhys; Moenius, Thomas; Rodriguez Perez, Maria Ines

Agent Davies Collison Cave

Pub. Number AU-A-2006257316

PCT Pub. Number WO2006/133904

Priority 0512091.0 14.06.05 GB

Filing date 13 June 2006

Wipo publication date 21 December 2006

International Classifications

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133904 Priority application(s): WO2006/133904

19 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257323-Hepatitis C virus nucleic acid vaccine

2006257288-2-(1H-indolylsulfanyl)-aryl amine derivatives